COMMUNIQUÉS West-GlobeNewswire

-
TerrAscend Announces Results of Annual General Meeting
24/06/2025 -
Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease
24/06/2025 -
Glass House Brands Inc. Announces Voting Results Following Annual and Special Meeting
24/06/2025 -
SciSparc Announces 1-for-21 Reverse Share Split
24/06/2025 -
First Steroid Cycle 2025: Experts Discuss Science Behind Beginner’s Guide to Choise Best Steroids for Muscle Growth, Bulking & Cutting By CrazyBulk
24/06/2025 -
Inventprise Announces Breakthrough in COVID-19 Conjugate Vaccine Study Published in Vaccine Journal
24/06/2025 -
Hapbee Delivers Breakout Q1 2025: Record Growth, Leaner Operations, and a Clear Path to Scalable Profitability
24/06/2025 -
Major shareholder notification – BlackRock, Inc.
24/06/2025 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 25 - 2025
24/06/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2025
24/06/2025 -
Applied StemCell Launches hiEX™ Research iPSC Exosomes to Power Next-Generation Regenerative Medicine Research
24/06/2025 -
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING
24/06/2025 -
Lulutox Tea UK (Lulutox Tea Detox) Officially Launches in Ireland, USA, Australia & Canada for Natural Digestive Cleanse
24/06/2025 -
Clariane place avec succès une émission obligataire de 400 millions d’euros
24/06/2025 -
Clariane has successfully completed a bond issue of 400 million euros
24/06/2025 -
CROSSJECT annonce le vif succès de son augmentation de capital portée à 5,7 millions d’euros après exercice intégral de la clause d’extension
24/06/2025 -
CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause
24/06/2025 -
Arcoma AB successfully completes directed share issue of SEK 11.0 million (~ EUR 1 million) (MAR)
24/06/2025 -
Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation
24/06/2025
Pages